FDA Inspection
Nuvisan GmbHNuvisan GmbH – FDA Inspection, Apr 26, 2016
Record Details
This FDA Inspection record concerns Nuvisan GmbH, with an inspection on April 26, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Nuvisan GmbH
- Inspection Date
- April 26, 2016
- Product Type
- Drugs
View Company Profile
ID · 354f11be-5254-4828-9918-9e758c392ec3
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 972661
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.68(b)Computer control of master formula records
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.186(a)Written procedures followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Nuvisan GmbH
1| Date | Classification | Office | Project area |
|---|---|---|---|
| January 11, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Nuvisan GmbH
- FDA Inspection 1242167 - 2022-01-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.